Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
VAR [NYSE]
Varian Medical Systems, Inc.
IndexS&P 500 P/E22.93 EPS (ttm)3.84 Insider Own0.20% Shs Outstand99.98M Perf Week3.39%
Market Cap8.80B Forward P/E17.77 EPS next Y4.95 Insider Trans19.05% Shs Float99.68M Perf Month0.43%
Income403.70M PEG1.91 EPS next Q0.87 Inst Own92.60% Short Float6.59% Perf Quarter7.89%
Sales3.05B P/S2.89 EPS this Y-3.80% Inst Trans-2.56% Short Ratio8.34 Perf Half Y4.10%
Book/sh15.83 P/B5.56 EPS next Y12.98% ROA11.80% Target Price88.50 Perf Year14.68%
Cash/sh9.16 P/C9.61 EPS next 5Y12.00% ROE24.10% 52W Range75.86 - 89.90 Perf YTD13.32%
Dividend- P/FCF24.48 EPS past 5Y7.60% ROI19.50% 52W High-2.07% Beta0.87
Dividend %- Quick Ratio1.60 Sales past 5Y6.60% Gross Margin42.70% 52W Low16.06% ATR1.47
Employees6800 Current Ratio2.10 Sales Q/Q5.50% Oper. Margin19.00% RSI (14)59.45 Volatility2.01% 1.57%
OptionableYes Debt/Eq0.27 EPS Q/Q-5.60% Profit Margin13.20% Rel Volume1.44 Prev Close87.17
ShortableYes LT Debt/Eq0.24 EarningsJan 28 AMC Payout0.00% Avg Volume787.48K Price88.04
Recom2.20 SMA200.74% SMA503.69% SMA2005.49% Volume1,131,517 Change1.00%
Oct-23-14Reiterated ISI Group Neutral $86 → $82.50
Oct-23-14Reiterated Brean Capital Buy $95 → $85
Jun-30-14Initiated ISI Group Neutral $90
Jan-23-14Reiterated Brean Capital Buy $80 → $95
Dec-04-12Reiterated Cantor Fitzgerald Hold $63 → $70
Nov-16-12Initiated The Benchmark Company Buy $88
Jul-26-12Downgrade Cantor Fitzgerald Buy → Hold
May-02-12Upgrade Barrington Research Mkt Perform → Outperform
Feb-13-12Upgrade Robert W. Baird Neutral → Outperform $72 → $76
Jan-03-12Reiterated Kaufman Bros Buy $68 → $72
Sep-22-11Initiated Kaufman Bros Buy $64
Aug-22-11Reiterated Ticonderoga Buy $80 → $68
Jul-28-11Downgrade Robert W. Baird Outperform → Neutral $81 → $72
Jul-11-11Upgrade Ticonderoga Neutral → Buy $84
Dec-30-10Initiated Wedbush Outperform $80
Jun-16-10Initiated Gleacher & Company Neutral
Apr-09-10Reiterated Jefferies Buy $57 → $64
Jan-05-10Initiated Jefferies & Co Buy $55
Nov-25-09Initiated Wells Fargo Market Perform
Nov-02-09Upgrade Soleil Hold → Buy $35 → $52
Dec-17-14 04:18PM  VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:10PM  Varian Medical Systems Announces Intention to Acquire MeVis Medical Solutions AG through a Public Tender Offer PR Newswire
Dec-11-14 12:40PM  Varian (VAR) Now a Strong Sell on Challenging Q1 Outlook Zacks
Dec-10-14 06:09PM  Final Glance: Health Care Equipment companies AP
01:19PM  Midday Glance: Health Care Equipment companies AP
10:41AM  Early Glance: Health Care Equipment companies AP
Dec-09-14 08:00AM  Varian Medical Systems Schedules First Quarter FY2015 News Release and Conference Call PR Newswire
Dec-03-14 12:50PM  Varian Medical (VAR) to Display New Technologies at RSNA Zacks
Dec-01-14 08:00AM  Varian to Exhibit X-ray Imaging Components Optimized for Flexibility and Fast Patient Throughput PR Newswire
Nov-29-14 01:04PM  VARIAN MEDICAL SYSTEMS INC Financials EDGAR Online Financials
Nov-25-14 06:02AM  VARIAN MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report EDGAR Online
Nov-20-14 08:00AM  Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto PR Newswire
Nov-14-14 02:20PM  Varian Medical (VAR) Down to Strong Sell on Dismal Q3 Zacks
Nov-12-14 08:00AM  Varian Medical Systems to Highlight the Latest Digital Detectors and X-ray Tubes at the MEDICA 2014 International Trade Fair PR Newswire
Nov-11-14 08:00AM  New Cancer Center at Guy's Hospital in London to be Equipped with Varian TrueBeam Treatment Machines PR Newswire
Nov-06-14 01:31PM  Varian Medical Systems CEO Dow Wilson Appointed to the President's Advisory Council on Doing Business in Africa PR Newswire
Oct-29-14 08:00AM  Doctors at Innovative Cancer Institute in Miami Use New Radiosurgery System to Treat Tumor Encroaching on Patient's Spinal Cord PR Newswire
Oct-28-14 07:00AM  4 Stocks Triggering Breakout Trades With Unusual Volume at TheStreet
Oct-27-14 08:00AM  GenesisCare Commences Cancer Treatments Using Queensland's First TrueBeam Medical Linear Accelerator for Image-Guided Radiotherapy PR Newswire
Oct-23-14 12:40PM  Varian Medical Systems Misses on Q4 Earnings and Revenues Zacks
08:00AM  UK's NHS Supply Chain Selects 10 TrueBeam Treatment Machines to Enable More Advanced Cancer Treatments PR Newswire
Oct-22-14 05:15PM  Varian misses Street 4Q forecasts AP
04:29PM  VARIAN MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:05PM  Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2014 PR Newswire
07:07AM  Q4 2014 Varian Medical Systems, Inc. Earnings Release - After Market Close CCBN
Oct-21-14 12:10PM  Will Varian Medical Systems (VAR) Miss Earnings Estimates? Zacks
Oct-14-14 08:00AM  Varian Medical Systems Schedules Investor Meeting for Year-End Review of Fiscal 2014 PR Newswire
Oct-06-14 10:30AM  Earnings season begins: Bright spots and worries at CNBC
Oct-01-14 08:00AM  Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call PR Newswire
Sep-16-14 12:40PM  Varian Medical Systems Joins Hands with Software Company Zacks
Sep-15-14 02:10PM  Varian Medical Systems Installs Proton Therapy at Scripps Zacks
08:00AM  Varian Medical Systems and Infor to Add New Data Integration Capability within Varian Software Suite for Planning, Managing, and Delivering Cancer Care PR Newswire
Sep-12-14 01:14PM  Varian Medical Systems Completes Commissioning of Five Proton Therapy Treatment Rooms Plus Deployment of ProBeamĀ® System Upgrade at Scripps Proton Therapy Center PR Newswire
Sep-11-14 12:40PM  Varian Medical Systems Unveils New Technologies Zacks
08:00AM  Varian Treatment Planning Support for Siemens Modulated Arc (mARC) Treatments to be Highlighted at 2014 ASTRO Meeting in San Francisco PR Newswire
Sep-09-14 08:00AM  Varian Medical Systems to Debut InSightive Analytics, an Interactive Dashboard and Visualization Solution for Oncology Professionals, At ASTRO 2014 PR Newswire
08:00AM  Varian Medical Systems' ASTRO Exhibit Spotlights Technology and Software that Support Knowledge Sharing Among Oncology Professionals PR Newswire
Sep-05-14 06:00AM  Varian Medical Systems Publishes 2014 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements PR Newswire
Aug-28-14 12:50PM  Varian Medical Expands Utah Facility, Creates 1000 New Jobs Zacks
Aug-27-14 02:40PM  Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake PR Newswire
Aug-20-14 01:04PM  3 Stocks Pulling The Health Services Industry Downward at TheStreet
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, and cancer care clinics. The Imaging Components segment provides X-ray imaging components to large imaging system original equipment manufacturers (OEMs) for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, and industrial applications; and X-ray tubes and flat panel digital image detectors to small OEMs, independent service companies, and end-users for filmless X-ray imaging. This segment also offers Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. Varian Medical Systems, Inc. also provides products and systems for delivering proton therapy; and develops various technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUERTIN TIMOTHY EDirectorDec 11Option Exercise52.71105,0005,535,050114,040Dec 12 01:19 PM
GUERTIN TIMOTHY EDirectorDec 11Sale86.67105,0009,100,36159,040Dec 12 01:19 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Dec 09Option Exercise68.8477553,35113,105Dec 10 02:48 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Dec 09Sale88.0172563,80712,705Dec 10 02:48 PM
FINNEY ELISHA WExec VP and CFODec 01Option Exercise51.6921,0001,085,56025,671Dec 02 08:10 PM
FINNEY ELISHA WExec VP and CFODec 01Sale88.7221,0001,863,1304,671Dec 02 08:10 PM
FINNEY ELISHA WExec VP and CFONov 24Sale88.242,930258,5324,671Nov 24 08:21 PM
FINNEY ELISHA WExec VP and CFONov 17Sale87.711,837161,1234,671Nov 18 04:47 PM
KUO JOHN WSVP, Gen Counsel and SecretaryNov 11Option Exercise57.9060635,08714,667Nov 12 08:04 PM
KUO JOHN WSVP, Gen Counsel and SecretaryNov 11Sale86.6360652,49914,061Nov 12 08:04 PM
NAUMANN-ETIENNE RUEDIGERDirectorNov 10Option Exercise64.735,000323,6505,000Nov 12 08:01 PM
NAUMANN-ETIENNE RUEDIGERDirectorNov 10Sale85.315,000426,5330Nov 12 08:01 PM
GUERTIN TIMOTHY EDirectorNov 03Option Exercise52.6180,0004,208,800128,683Nov 04 07:24 PM
GUERTIN TIMOTHY EDirectorNov 03Sale83.7280,0006,697,77148,683Nov 04 07:24 PM
FINNEY ELISHA WExec VP and CFOOct 29Option Exercise52.8310,000528,30014,671Oct 30 08:56 PM
FINNEY ELISHA WExec VP and CFOOct 29Sale83.9510,000839,5004,671Oct 30 08:56 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Oct 27Option Exercise63.891,41590,4079,176Oct 28 09:33 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Oct 27Sale81.001,240100,4408,401Oct 28 09:33 PM
FINNEY ELISHA WExec VP and CFOOct 01Option Exercise50.6615,000759,90019,496Oct 02 08:42 PM
FINNEY ELISHA WExec VP and CFOOct 01Sale79.9815,0001,199,6944,496Oct 02 08:42 PM
KUO JOHN WSVP, Gen Counsel and SecretarySep 11Option Exercise57.9060535,03014,666Sep 12 05:27 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Sep 11Option Exercise57.9064137,1148,293Sep 12 05:25 PM
KUO JOHN WSVP, Gen Counsel and SecretarySep 11Sale85.8260551,92314,061Sep 12 05:27 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Sep 09Option Exercise68.8477653,4207,652Sep 10 08:20 PM
FINNEY ELISHA WExec VP and CFOSep 02Option Exercise51.2020,0001,024,05024,496Sep 03 08:46 PM
FINNEY ELISHA WExec VP and CFOSep 02Sale85.1820,0001,703,6044,496Sep 03 08:46 PM
THYAGARAJAN VENKATRAMANDirectorAug 20Option Exercise64.735,000323,6509,742Aug 20 07:31 PM
THYAGARAJAN VENKATRAMANDirectorAug 20Sale84.255,000421,2504,742Aug 20 07:31 PM
KUO JOHN WSVP, Gen Counsel and SecretaryAug 11Option Exercise57.9060635,08714,667Aug 12 04:04 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Aug 11Option Exercise63.901,41690,4767,012Aug 12 04:06 PM
KUO JOHN WSVP, Gen Counsel and SecretaryAug 11Sale85.0760651,55014,061Aug 12 04:04 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Aug 11Sale85.0377665,9856,236Aug 12 04:06 PM
FINNEY ELISHA WExec VP and CFOAug 01Option Exercise50.6615,000759,90019,496Aug 04 03:09 PM
GUERTIN TIMOTHY EDirectorAug 01Option Exercise52.6180,0004,208,800128,683Aug 04 03:06 PM
FINNEY ELISHA WExec VP and CFOAug 01Sale81.6615,0001,224,8904,496Aug 04 03:09 PM
GUERTIN TIMOTHY EDirectorAug 01Sale81.6980,0006,534,90448,683Aug 04 03:06 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jul 14Option Exercise57.9064137,1146,877Jul 14 09:44 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jul 14Sale85.1264154,5656,236Jul 14 09:44 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 11Option Exercise57.9060535,03014,666Jul 14 09:41 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 11Sale84.9660551,40014,061Jul 14 09:41 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jul 09Option Exercise68.8477553,3517,011Jul 10 08:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 09Option Exercise68.8458240,06514,643Jul 10 08:15 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jul 09Sale84.6977565,6336,236Jul 10 08:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJul 09Sale85.0058249,47014,061Jul 10 08:15 PM
FINNEY ELISHA WExec VP and CFOJul 01Option Exercise51.2020,0001,024,05024,496Jul 02 03:38 PM
FINNEY ELISHA WExec VP and CFOJul 01Sale83.8620,0001,677,2234,496Jul 02 03:38 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 23Option Exercise68.841,745120,12615,806Jun 24 07:11 PM
KUO JOHN WSVP, Gen Counsel and SecretaryJun 23Sale85.001,745148,32514,061Jun 24 07:11 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jun 16Option Exercise0.001,41607,012Jun 18 03:07 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Jun 16Sale82.421,416116,7046,236Jun 18 03:07 PM
FINNEY ELISHA WExec VP and CFOJun 02Option Exercise50.6610,000506,60014,496Jun 03 07:56 PM
FINNEY ELISHA WExec VP and CFOJun 02Sale82.3510,000823,4954,496Jun 03 07:56 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.May 12Option Exercise57.9064137,1146,877May 12 08:36 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Option Exercise57.9060535,03014,666May 12 08:41 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMay 12Sale82.7960550,08714,061May 12 08:41 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.May 12Sale82.8264153,0856,236May 12 08:36 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.May 09Option Exercise68.8477653,4207,012May 12 08:36 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.May 09Sale81.2677663,0566,236May 12 08:36 PM
FINNEY ELISHA WExec VP and CFOMay 01Option Exercise51.8310,000518,30014,496May 02 05:48 PM
GUERTIN TIMOTHY EDirectorMay 01Option Exercise47.0480,0003,763,500128,683May 02 05:44 PM
FINNEY ELISHA WExec VP and CFOMay 01Sale78.9910,000789,8714,496May 02 05:48 PM
GUERTIN TIMOTHY EDirectorMay 01Sale78.9880,0006,318,67248,683May 02 05:44 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Apr 11Option Exercise57.9064037,0566,876Apr 15 04:28 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 11Option Exercise57.9060635,08714,326Apr 15 04:30 PM
KUO JOHN WSVP, Gen Counsel and SecretaryApr 11Sale80.7760648,94413,720Apr 15 04:30 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Apr 11Sale80.9064051,7756,236Apr 15 04:28 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Apr 09Option Exercise68.8477553,3517,011Apr 10 08:41 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Apr 09Sale83.5677564,7626,236Apr 10 08:41 PM
FINNEY ELISHA WExec VP and CFOApr 01Option Exercise52.6110,000526,10014,308Apr 02 06:20 PM
FINNEY ELISHA WExec VP and CFOApr 01Sale83.9710,000839,7314,308Apr 02 06:20 PM
VERHOEF CLARENCE RSVP, Finance, Corp ControllerMar 17Sale84.701,14096,562768Mar 17 08:33 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Mar 11Option Exercise57.9064137,1146,877Mar 11 07:12 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 11Option Exercise68.179,913675,78123,633Mar 12 05:07 PM
KUO JOHN WSVP, Gen Counsel and SecretaryMar 11Sale84.989,913842,44713,720Mar 12 05:07 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Mar 11Sale84.8064154,3566,236Mar 11 07:12 PM
GUERTIN TIMOTHY EDirectorMar 10Option Exercise37.1780,0002,973,600128,683Mar 11 07:09 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Mar 10Option Exercise68.8477653,4207,012Mar 11 07:12 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Mar 10Sale84.0677665,2296,236Mar 11 07:12 PM
GUERTIN TIMOTHY EDirectorMar 10Sale84.0580,0006,723,83548,683Mar 11 07:09 PM
FINNEY ELISHA WExec VP and CFOMar 03Option Exercise52.6110,000526,10014,308Mar 04 05:26 PM
FINNEY ELISHA WExec VP and CFOMar 03Sale83.4110,000834,0664,308Mar 04 05:26 PM
NAUMANN-ETIENNE RUEDIGERDirectorFeb 21Option Exercise60.323,000180,9604,411Feb 24 06:16 PM
NAUMANN-ETIENNE RUEDIGERDirectorFeb 21Sale83.994,411370,4680Feb 24 06:16 PM
LARET MARK RDirectorFeb 21Sale84.061,411118,6090Feb 24 06:13 PM
THYAGARAJAN VENKATRAMANDirectorFeb 18Option Exercise0.001,41105,005Feb 19 08:29 PM
NAUMANN-ETIENNE RUEDIGERDirectorFeb 18Option Exercise0.001,41101,411Feb 19 08:26 PM
LARET MARK RDirectorFeb 18Option Exercise0.001,41101,411Feb 19 08:23 PM
ECKERT R ANDREWDirectorFeb 18Option Exercise0.001,41106,394Feb 19 08:20 PM
BOSTROM SUSAN LDirectorFeb 18Option Exercise0.001,41102,264Feb 19 08:17 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Feb 11Option Exercise57.9064037,0566,876Feb 11 08:35 PM
KUO JOHN WSVP, Gen Counsel and SecretaryFeb 11Option Exercise57.9060535,03014,325Feb 11 08:41 PM
KUO JOHN WSVP, Gen Counsel and SecretaryFeb 11Sale80.6260548,77613,720Feb 11 08:41 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Feb 11Sale80.6764051,6326,236Feb 11 08:35 PM
ECKERT R ANDREWDirectorFeb 10Option Exercise60.325,000301,60010,870Feb 11 08:27 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Feb 10Option Exercise68.8477653,4207,012Feb 11 08:35 PM
KENNEDY KOLLEEN TSVP and Pres. Oncology Sys.Feb 10Sale80.5277662,4816,236Feb 11 08:35 PM
ECKERT R ANDREWDirectorFeb 10Sale80.525,887474,0074,983Feb 11 08:27 PM
FINNEY ELISHA WExec VP and CFOFeb 03Option Exercise52.6110,000526,10014,308Feb 05 01:28 PM
LEVY RICHARD MDirectorFeb 03Option Exercise39.8520,000797,00020,000Feb 05 01:33 PM
GUERTIN TIMOTHY EDirectorFeb 03Option Exercise37.1725,000929,25073,683Feb 05 01:52 PM